INTERNISTI E BPCO
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
Dr Robert Young_AsthmaFoundation.v5.2017
The role of LABA/LAMA and add-on therapies in the management of... | Download Scientific Diagram
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
Frontiers | Single Inhaler LABA/LAMA for COPD
Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
Page 14 - Rivista SIMG 1 - Maggio 2023 - web
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal | COPD
Trelegy Ellipta is the first triple inhaler in the US, featuring a LAMA/LABA /ICS combination. Though it was FDA approved 1 full … | Inhaler, Labas, Ambulatory care
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
LABA/LAMA vs ICS/LABA for exacerbations - Management of Stable COPD - GOLD COPD 2017 Resource Center: Activity Five
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
Avances En Respiratorio | LAMA/LABA vs. LABA/ICS: la evidencia Cochrane | Notícias
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
